Navigation Links
SARS: a model disease
Date:11/20/2007

A new model to predict the spread of emerging diseases has been developed by researchers in the US, Italy, and France. The model, described in the online open access journal BMC Medicine, could give healthcare professionals advance warning of the path an emerging disease might take and so might improve emergency responses and control.

Severe acute respiratory syndrome (SARS) spread rapidly in 2002-2003, revealing just how vulnerable we might be to emerging diseases and how global transportation is critical to the spread of an epidemic.

Now, Vittoria Colizza and Alessandro Vespignani of Indiana University, Bloomington, USA and the Institute for Scientific Interchange Foundation, in Turin, Italy, and colleagues in France have developed a predictive model of the spread of emerging diseases based on actual travel and census data for more than three thousand urban areas in 220 countries. The model provides predictions of how likely an outbreak will be in each region and how widespread it might become. The research highlights just how the accuracy in predicting the spreading pattern of an epidemic can be related to clearly identifiable routes by which the disease could spread.

In order to assess the predictive power of their model, the researchers turned to the historical records of the global spread of the SARS virus. They evaluated the initial conditions before the disease had spread widely, based on the data for the arrival of the first patient who left mainland China for Hong Kong, and for the resulting outbreak there. They then simulated the likelihood that SARS would emerge in specific countries thereafter, as brought by infectious travelers. The simulated results fit very accurately with the actual pattern of the spread of SARS in 2002. Analysis of the results also identified possible paths of the virus' spread along the routes of commercial air travel, highlighting some preferred channels which may serve as epidemic pathways for th
'/>"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. Health care incentive model offers collaborative approach
3. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
4. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
5. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
6. New knock-out gene model provides molecular clues to breast cancer
7. Rain Man mice provide model for autism
8. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
9. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
10. Americas Next Top Model Steps up for Psoriasis Awareness
11. Computer models help raise the bar for sporting achievement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... debunks the ,something,s wrong with being single, myth , , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
(Date:12/4/2009)... Systems (NYSE: VAR ) announced today that its ... of Stockholders for February 11, 2010 with a record date ... the Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo ... be webcast by Thomson Financial and can be accessed at ...
(Date:12/4/2009)... The American Association of Homes and Services for the Aging ... Living and Supportive Services (CLASS) provisions remain in the final ... providing support to elders, people with disabilities and their caregivers. ... care reform bill that will make it affordable to care ...
(Date:12/4/2009)... While Congress debates whether health care reform ... point to 45 hospitals that lead through example ... nation while attaining the highest levels of efficiency. ... have been named 2009 Leapfrog Top Hospitals, based ...
(Date:12/4/2009)... Western Reserve University researchers, from the School of Medicine,s ... which products of lipid peroxidation and some drugs of ... identified by a combination of metabolomics and mass isotopomer ... of action of the drug of abuse gamma-hydroxybutyrate, also ...
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... a woman; much like the association between a successful man and a ... to be goaded to see a doctor, that too by a woman, ... or even a female friend. ,A News poll revealed that ... after being coaxed and cajoled into seeing one. ,Advising ...
... his government's move to allow the introduction of generic versions ... property rights in the kingdom. ,"We still defend ... to other countries as well the world community," Surayud was ... Na Songkhla will be traveling to the United along with ...
... vitamin for longevity! Not yet, but a Dartmouth discovery that ... tantalizing possibility a step closer. ,The research, reported ... new vitamin extends lifespan in yeast cells, much like calorie ... developing supplements to benefit humans. ,Radical calorie reduction ...
... Pennsylvania, is recalling half-gallon packages of Galliker's Acidophilus Plus ... milk may be unsafe. It has not been shown ... the raw milk itself to determine the presence or ... is free of infectious organisms. Only products with the ...
... allergy is increasingly common, affecting one in 70 schoolchildren, available ... the allergy. ,A joint team of scientists ... St Thomas' hospital, are taking up a seven-year study and ... ,The babies being studied are between four and ...
... US. A Defence Department panel has warned that continued ... on two fronts. ,One, soldiers are at an ... current level of staffing and funds, the military health care ... ,In a damning revelation, the Defense Department's ...
Other Medicine News:Health News:Thailand Unfazed As US Worries Over Copyright Violations 2Health News:Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find 2Health News:Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find 3Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
(Date:12/3/2009)... YORK, Dec. 3 Guidepoint Global, LLC , a ... Sleep Apnea Tracker, a monthly longitudinal data release that monitors ... Apnea market. ,, The Sleep Apnea Tracker captures actual ... in the United States from 15 different equipment providers going ...
(Date:12/3/2009)... Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ... innovative small molecule drugs for the treatment of immune ... host a webcast and conference call on, Tuesday, December ... and 8:00am Pacific Time) to discuss clinical data regarding ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Smart Balance Announces 2009 Second Quarter Results 53838 1Smart Balance Announces 2009 Second Quarter Results 53838 2Smart Balance Announces 2009 Second Quarter Results 53838 3Smart Balance Announces 2009 Second Quarter Results 53838 4Smart Balance Announces 2009 Second Quarter Results 53838 5Smart Balance Announces 2009 Second Quarter Results 53838 6Smart Balance Announces 2009 Second Quarter Results 53838 7Smart Balance Announces 2009 Second Quarter Results 53838 8Smart Balance Announces 2009 Second Quarter Results 53838 9Smart Balance Announces 2009 Second Quarter Results 53838 10Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 1Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 2Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 3
... This Patient ... Population -, ... and Bristol-Myers Squibb Company (NYSE: BMY ),announced today that the ... for ABILIFY(R) (aripiprazole) for the,acute treatment of manic and mixed episodes ...
... 275 residents screened for HIV during three testing days ... of,February, Test for Life worked with the Washington Wizards, ... Washington, DC,to offer free and confidential HIV testing to ... at the Temple of Praise,Whitman-Walker and Us Helping Us ...
Other Medicine Technology:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 2U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 3U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 4U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 5U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 6U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 7U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 8U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 9Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS 2
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products: